Vector Science and Therapeutics Corp. enters investor relations agreement
Vector Science and Therapeutics Corp. has entered into an investor relations agreement with RedChip Companies, Inc. The agreement covers the management of the company's investor relations functions.
Mequon, Wisconsin. Vector Science and Therapeutics Corp. announced it has signed an investor relations agreement with RedChip Companies, Inc. The agreement is intended to manage the company's investor relations activities.
Under the terms of the agreement, RedChip Companies will oversee Vector Science and Therapeutics' investor relations efforts. Company CEO, Dr. Joseph M. Stauffer, stated that the collaboration is expected to enhance the company's visibility and provide investors with a clearer understanding of its strategy and prospects. The company also granted options to acquire shares as part of this arrangement.
Vector Science and Therapeutics is focused on developing novel therapeutic approaches for pain conditions. Specific financial terms of the agreement were not disclosed. The company is listed on the TSXV.
Outsourcing investor relations functions is a common strategy for smaller public companies aiming to increase investor engagement and liquidity without expanding in-house teams.